UK breast cancer patients receive proton beam therapy in a world-first NHS trial

Proton radiation therapyIt was used to treat breast cancerPatients worldwide NHSTry to describe its promise as an option to Radiation therapy.

Radiotherapy is very efficient and causes very few side effects for the majority of the 30,000 breast implants. cancerAccording to Professor Charlotte Coles of Addenbrooke’s Hospital, the treatment is given annually to patients.

Radiation therapy is a risky treatment that can cause cancer in a small percentage of patients (around 500 per year). heartProblems occur in less that 1 percent of recipients.

This group will be invited to participate in it sermon– Professor Coles’ new NHS trial, which will include 192 patients at 22 locations in the UK, is designed to determine if proton beam therapy might be a better option.

To target tumors more precisely, proton beam therapy uses charged particles rather than X-rays. Researchers hope it will allow doctors and nurses to administer the radiation therapy when necessary, with less radiation to the heart and without increasing the risk for infection. Side effects that may occur early include reddening skin and changes in breast appearance.

It is currently available only to patients with cancer who are registered at the NHS in London or Manchester. It is more expensive than standard radiotherapy and is not available to everyone. It is primarily used for Treating children with brain tumorsThere have not been large trials in breast cancer patients.

Participants in the trial will be treated with either proton radiation therapy or standard radiation therapy. They will also complete questionnaires to record their experiences so that researchers can evaluate side effects such as skin reactions and breast pain.

To avoid the need to have a long follow up of several years, the trial will measure the dose delivered to the heart to detect potential heart problems early.

Professor Judith Bliss of Institute of Cancer Research said that this early predictor will help us discover the potential benefits of proton beam treatment for long-term heart health over the years, rather than the decades.

Kim Jones, a 44 year-old woman from Ely in Cambridgeshire was one of the first to be recruited. She noticed a thickening of her skin and tingling pains in her breasts.

Ms Jones had already received chemotherapy, a mastectomy at Addenbrooke’s and removal of lymph nodes at Addenbrooke’s. She was then accepted into the Barabel trial. Ms Jones began proton beam therapy at Christie’s NHS Foundation Trust Manchester on 24/10.

“When I was told that I had been accepted into trial, I felt very fortunate to have had the opportunity to get this treatment,” Kim said. “Clinical trials, which are the best way for you to determine which treatments work best, are very important.”

Radiotherapy is unlikely to cause heart problems later on in life. This is often because patients’ breast tissue or lymph nodes are located near the heart or because of an increased risk of developing heart problems.

However, it is possible for the average radiotherapy dose to be calculated for the heart. This information can then be combined with your medical history to predict the lifetime risk of developing heart disease.

Proton beam therapy has been used in some countries to treat breast cancer, but the number of people involved in these trials is small. No trials directly comparing proton therapy with standard radiation therapy were reported.

Professor Coles stated that “Although only a small number of people are affected later in life by an increased risk of developing heart disease, it is still a serious problem.”

“Most radiotherapy patients have decades of good health ahead of them. We must do everything possible to avoid any future heart problems.